Intelligent Bio Solutions (NASDAQ:INBS) · earnings beat
Quarter
Q1
EPS estimate to actual
-$1.31→ to -$0.86
Revenue estimate to actual
$1.4M→ to $1.4M
At a glance
Key takeaways
01Intelligent Bio Solutions reported Q1 EPS of -$0.86, beating the consensus estimate of -$1.31 by $0.45 per share on November 10, 2026.
02Revenue came in at $1.4M, matching the estimate with no variance reported.
03The company's stock trades at $2.22 with a market capitalization of $4.7M.
04This represents a 34% earnings beat relative to consensus, following a 43% beat in the prior quarter.
Earnings Results
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly earnings results on November 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.86, beating the consensus estimate of $-1.31 by $0.45 per share. Revenue came in at $1.4M, missing the estimate of $1.4M.
Company Overview
Intelligent Bio Solutions's stock moved following the earnings release. The stock currently trades at $2.22 with a market capitalization of $4.7M.
Intelligent Bio Solutions's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 34% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Intelligent Bio Solutions should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.